Institution
Exponent
Company•Menlo Park, California, United States•
About: Exponent is a company organization based out in Menlo Park, California, United States. It is known for research contribution in the topics: Population & Risk assessment. The organization has 1589 authors who have published 2680 publications receiving 88140 citations.
Papers published on a yearly basis
Papers
More filters
TL;DR: A proof of concept extension of the MOA framework is proposed for scoring confidence in the supporting data to improve scientific justification for MOA use in characterizing hazards and selecting dose‐response extrapolation methods for specific chemicals.
45 citations
TL;DR: A nested case-control study of 128 incident Hodgkin lymphoma cases and 368 matched controls from active-duty military personnel with archived serum in the US Department of Defense Serum Repository was conducted to determine whether a panel of anti-EBV antibody titers differed in EBV(+) and EBV
45 citations
Exponent1, University of Guelph2, United States Environmental Protection Agency3, World Maritime University4, University of York5, Massachusetts Institute of Technology6, Louisiana State University7, University of Massachusetts Boston8, Michigan Department of Environmental Quality9, Saint Mary's University10, Baylor University11, Procter & Gamble12, University of Florida13, George Washington University14, Wilmington University15, Clemson University16, University of Wisconsin–Milwaukee17, Canadian Food Inspection Agency18, Ohio State University19, Shell Oil Company20, University of Houston21, National Institute of Standards and Technology22, United States Department of Agriculture23, National Autonomous University of Mexico24, Indiana University25, United States Geological Survey26, Southern California Coastal Water Research Project27, Queen's University28
TL;DR: 40 priority research questions following engagement of scientists and engineers in North America are reported and discussed, identifying the importance of stimulating innovation and developing new methods, tools, and concepts in environmental chemistry and toxicology to improve assessment and management of chemical contaminants and other diverse environmental stressors.
Abstract: Anticipating, identifying, and prioritizing strategic needs represent essential activities by research organizations. Decided benefits emerge when these pursuits engage globally important environment and health goals, including the United Nations Sustainable Development Goals. To this end, horizon scanning efforts can facilitate identification of specific research needs to address grand challenges. We report and discuss 40 priority research questions following engagement of scientists and engineers in North America. These timely questions identify the importance of stimulating innovation and developing new methods, tools, and concepts in environmental chemistry and toxicology to improve assessment and management of chemical contaminants and other diverse environmental stressors. Grand challenges to achieving sustainable management of the environment are becoming increasingly complex and structured by global megatrends, which collectively challenge existing sustainable environmental quality efforts. Transdisciplinary, systems-based approaches will be required to define and avoid adverse biological effects across temporal and spatial gradients. Similarly, coordinated research activities among organizations within and among countries are necessary to address the priority research needs reported here. Acquiring answers to these 40 research questions will not be trivial, but doing so promises to advance sustainable environmental quality in the 21st century. Environ Toxicol Chem 2019;38:1606-1624. © 2019 The Authors. Environmental Toxicology and Chemistry published by Wiley Periodicals, Inc. on behalf of SETAC.
44 citations
TL;DR: The risk of bleeding combined with the lower rates of VTE with existingLower rates of chemoprophylaxis does not warrant the routine use of anticoagulation, and use of mechanical prophylaxis combined with aspirin may be sufficient for shoulder arthroplasty patients who are not at increased risk of Vte.
44 citations
University of Copenhagen1, Statens Serum Institut2, Stanford University3, Cancer Prevention Institute of California4, University of Southern California5, Karolinska Institutet6, Exponent7, Yale University8, Mario Negri Institute for Pharmacological Research9, University of Milan10, French Institute of Health and Medical Research11, University of York12, Imperial College London13, BC Cancer Agency14, University of British Columbia15, University of Toronto16, Mount Sinai Hospital17, University of Saskatchewan18, University of Burgundy19, German Cancer Research Center20, University Medical Center Freiburg21, International Agency for Research on Cancer22, Icahn School of Medicine at Mount Sinai23, University of Cagliari24
TL;DR: The results support the notion of etiologic heterogeneity between HL subtypes, highlighting the need for HL stratification in future studies, and emphasize that cigarette smoking should be added to the few modifiable HL risk factors identified.
44 citations
Authors
Showing all 1593 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Hans-Olov Adami | 145 | 908 | 83473 |
| Melvin E. Andersen | 83 | 517 | 26856 |
| Joseph Katz | 81 | 691 | 27793 |
| Lorna J. Gibson | 75 | 178 | 33835 |
| Buddhima Indraratna | 64 | 735 | 15596 |
| Barbara A. Goff | 61 | 227 | 11859 |
| Jack S. Mandel | 60 | 171 | 22308 |
| Antonio Gens | 58 | 269 | 14987 |
| Ellen T. Chang | 57 | 209 | 11567 |
| Dayang Wang | 55 | 185 | 9513 |
| Edmund Lau | 52 | 183 | 22520 |
| Steven M. Kurtz | 52 | 249 | 8066 |
| Alfred J. Crosby | 51 | 206 | 8310 |
| Suresh H. Moolgavkar | 51 | 169 | 8833 |
| Michael T. Halpern | 51 | 237 | 16566 |